About Aleva Neuro
Aleva Neuro is a company based in Lausanne (Switzerland) founded in 2008 by Claudio Pollo. Aleva Neuro has raised $57.05 million across 8 funding rounds from investors including The Michael J. Fox Foundation, CIP Merchant Capital and Greatbatch. Aleva Neuro offers products and services including directSTIM™ DBS System. Aleva Neuro operates in a competitive market with competitors including Openwater, Rune Labs, PhotoPharmics, PD Neurotechnology and Cala Health, among others.
- Headquarter Lausanne, Switzerland
- Founders Claudio Pollo
- Stage Minicorn
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aleva Neurotherapeutics Sa
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$57.05 M (USD)
in 8 rounds
-
Latest Funding Round
Not available
-
Investors
The Michael J. Fox Foundation
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aleva Neuro
Aleva Neuro offers a comprehensive portfolio of products and services, including directSTIM™ DBS System.
Provides directional stimulation for treating Parkinson's and essential tremor.
People of Aleva Neuro
Unlock access to complete
Unlock access to complete
Funding Insights of Aleva Neuro
Aleva Neuro has successfully raised a total of $57.05M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aleva Neuro
Aleva Neuro has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include The Michael J. Fox Foundation, CIP Merchant Capital and Greatbatch.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early to mid stage life sciences-focused VC firm investing in geographies such as Europe
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Aleva Neuro
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aleva Neuro
Investment portfolio details for Aleva Neuro
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aleva Neuro
Detailed financials for Aleva Neuro
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aleva Neuro Comparisons
Peer comparison for Aleva Neuro
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aleva Neuro
Aleva Neuro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Openwater, Rune Labs, PhotoPharmics, PD Neurotechnology and Cala Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of imaging technologies for medical diagnosis and treatments
|
|
| Locked | Locked | Locked |
Therapy management is enabled via a neuromodulation data platform.
|
|
| Locked | Locked | Locked |
Non-invasive phototherapy for Parkinson's disease is developed.
|
|
| Locked | Locked | Locked |
A wearable device is developed to monitor Parkinson's movement disorders.
|
|
| Locked | Locked | Locked |
Wearable neuromodulation devices for essential tremor relief are developed.
|
|
| Locked | Locked | Locked |
Inhaled pulmonary therapies for Parkinson's motor fluctuations are developed.
|
Detailed competitors of Aleva Neuro
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aleva Neuro
Complete news archive for Aleva Neuro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aleva Neuro
Aleva Neuro was founded in 2008.
Aleva Neuro is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Aleva Neuro is a funded company, having raised a total of $57.05M across 8 funding rounds to date.
Aleva Neurotherapeutics was founded in 2008 in Lausanne, Switzerland, within the neurostimulation sector. A MEMS-based neurostimulation platform is utilized to create micro deep brain stimulation technology, targeting conditions like Parkinsons disease and essential tremor. Implantable systems such as the directSTIM DBS System are produced, alongside diagnostic tools including the spiderSTIM DBS Diagnostic System, to support therapies for neurological disorders.
Aleva Neuro's top competitors include Rune Labs, Openwater and PhotoPharmics.
Aleva Neuro offers directSTIM™ DBS System.
Aleva Neuro has 9 investors. Key investors include The Michael J. Fox Foundation, CIP Merchant Capital, Greatbatch, BioMedPartners, and BB Biotech Ventures.
The valuation of Aleva Neuro is $54.2M as of Dec 2021.